Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Conditions
- Brain and Central Nervous System Tumors
Interventions
- BIOLOGICAL: bevacizumab
- DRUG: sorafenib tosylate
Sponsor
Alliance for Clinical Trials in Oncology
Collaborators